Ontology highlight
ABSTRACT: Rationale & objective
The use of renin-angiotensin system (RAS) inhibitors is standard of care in people with early to moderate chronic kidney disease (CKD). Less is known regarding the efficacy of RAS inhibitors in very advanced CKD. In this study, we describe patterns of use of RAS inhibitors and associations of these patterns of use with risk for CKD progression and mortality in patients with advanced CKD.Study design
Propensity-matched cohort study.Settings & participants
We identified 678 participants who were enrolled in the multicenter Chronic Renal Insufficiency Cohort (CRIC) Study with estimated glomerular filtration rates (eGFRs) < 30 mL/min/1.73 m2 at the baseline visit.Exposure
Use of RAS inhibitors within the first year after the base
SUBMITTER: Arora N
PROVIDER: S-EPMC7380396 | biostudies-literature | 2020 May-Jun
REPOSITORIES: biostudies-literature